It has been reported that SPP1/CD44 signaling in the glioma perivascular niche promotes aggressive tumor growth (Wei et al., 2019), and ITGB1 was related to the dismal OS in NSCLC (Zheng et al., 2016). Here, CD44 is linked to central nervous system cancer.